Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Eculizumab
Locations
23
United States
Burlington, Massachusetts, United States
Hackensack, New Jersey, United States
New York, New York, United States
Columbus, Ohio, United States
Houston, Texas, United States
Liège, Belgium
Start Date
July 1, 2010
Primary Completion Date
October 1, 2013
Completion Date
February 1, 2014
Last Updated
May 30, 2017
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions